Abstract
The role of modern technologies in management of Type 1 diabetes in children Type 1 diabetes (T1D) treatment in children has been changed significantly by the implementation of modern technologies into clinical practice in the last decade. Novel insulins and its combinations enables tailoring the insulin program personally in accord with the patients' needs.
Major changes have been achieved in the development of continuous glucose monitoring systems (CGM). These devices help our patients to follow, archive and analyze complete glycemic profiles, and - if necessary - to send it to the physician.
Modern insulin pumps sense data from CGM devices and adjust insulin dosage automatically to effectively prevent hypo- and hyperglycemia and prolong time in glycemic target. There is no doubt that the process of tighter connection between CGM and insulin pumps will continue in the near future aiming to develop full closed-loop system independent on patient's diet and regimen.
Current data show that such progress seems to be realistic in the relative short run.